Health
George Clinical Partners with Medidata to Unlock Operational Efficiency in Clinical Trials
Medidata's Rave Grants Manager will be implemented across 50 multinational studies and multiple therapeutic areas SYDNEY, Nov. 14, 2023 /PRNewswire/ -- Medidata, a Dassault Systèmes company, announced today that George Clinical, a leading global clinical research organization, is leveraging Med...
2023-11-14 10:48
1411
HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO
SYDNEY, Nov. 13, 2023 /PRNewswire/ -- HaemaLogiX Ltd, a clinical stage Australian biotech, is pleased to announce the appointment ofDamian Clarke-Bruce as Managing Director and CEO, effective13 November 2023. Outgoing CEO Bryce Carmine will remain active in the company, retaining his role as Cha...
2023-11-14 08:27
1056
Brii Bio Presents New Data Highlighting Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2023
Direct evidence that BRII-179-induced functional antibody responses can contribute to increased and sustained HBsAg loss rate New insight in utilizing BRII-179 to enriching patients with intrinsic humoral immune responses for higher HBsAg loss or HBV functional cure rates New data support ...
2023-11-14 06:40
1408
Brii Bio Presents New Data Highlighting Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2023
Direct evidence that BRII-179-induced functional antibody responses can contribute to increased and sustained HBsAg loss rate New insight in utilizing BRII-179 to enriching patients with intrinsic humoral immune responses for higher HBsAg loss or HBV functional cure rates New data support ...
2023-11-14 06:40
1242
Telix Announces Proposed Acquisition of QSAM Biosciences and Its Lead Therapy Candidate, CycloSam®
MELBOURNE, Australia, Nov. 14, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed a conditional Term Sheet to acquire QSAM Biosciences, Inc. (QSAM) and its lead asset, CycloSam® (Samarium-153-DOTMP). QSAM is a United States (U.S.) based...
2023-11-14 06:33
1223
Rx-360 Releases Two New Publications in Support of the Pharmaceutical Industry and Patient Safety
PHILADELPHIA, Nov. 14, 2023 /PRNewswire/ -- Rx-360 is pleased to announce that the consortium membership led by key members of the Supplier Quality Working Group have released two new papers this week to help drive best practices in pharmaceutical supply chain integrity and patient safety. The t...
2023-11-14 03:00
1357
SCG Cell Therapy Announces Late-Breaking Clinical Data at AASLD Showing SCG101 Improved Tumor Reponses and Achieved Sustained Antiviral Activates in Patients with Advanced HBV-related Hepatocellular Carcinoma
SINGAPORE, Nov. 14, 2023 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced late-breaking clinical data from its first-in-class autologous hepatitis B virus ...
2023-11-14 02:00
2334
More than two in three people with diabetes already have complications at diagnosis, International Diabetes Federation study finds
Global research from the International Diabetes Federation reveals that 72% of people living with diabetes only received their diagnosis because they had at least one of the related complications – such as loss of vision, nerve damage or heart disease. BRUSSELS, Nov. 14, 2023 /PRNewswire/ -- Sev...
2023-11-14 00:36
1444
Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries
Program aims to address key barriers to genomic sequencing in-country SAN DIEGO, Nov. 13, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the launch of the Global Health Access Initiative to support access to p...
2023-11-13 22:15
1462
LIFE FITNESS ANNOUNCES SYMBIO, A FIRST-OF-ITS-KIND PREMIUM CARDIO LINE, REIMAGINING THE FITNESS EXPERIENCE
ROSEMONT, Ill., Nov. 13, 2023 /PRNewswire/ -- Life Fitness, the global leader
in commercial fitness equipment, today announced the launch of its cardio line,
Symbio™, an immersive, four-machine collection.
2023-11-13 22:00
1916
Lunit, a Founding Member of CancerX, Showcased in the Inaugural Project to Improve Equity and Reduce Financial Toxicity in Cancer Care
- Lunit INSIGHT suite, Lunit's AI-driven solutions for early detection of cancer, featured in CancerX's first official project: enhancing equity and reducing financial burden in cancer care SEOUL, South Korea, Nov. 13, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered ...
2023-11-13 22:00
1149
OliPass Discloses Painful but Hilarious Clinical Findings from a Phase 2a Trial in OA Patients with Nav1.7 Selective Inhibitor OLP-1002
SEOUL, South Korea, Nov. 13, 2023 /PRNewswire/ -- OliPass Corporation, an RNA therapeutics platform company, disclosed uncanny clinical findings from a multi-center Phase 2a trial with Nav1.7 selective OLP-1002 in osteoarthritis (OA) patients with moderate to severe pain inAustralia with Novotech...
2023-11-13 22:00
1129
Agora Announces RTE Telehealth, A Webinar Exploring the Impact of AI and AR/VR in Virtual Healthcare
The dual session will explore how emerging technologies can improve patient interaction and healthcare delivery in telehealth SANTA CLARA, Calif., Nov. 13, 2023 /PRNewswire/ -- Agora, Inc. (NASDAQ: API), a pioneer and leading platform for real-time engagement APIs, has announced its RTE Teleheal...
2023-11-13 22:00
1288
Datasea Reports First Quarter Fiscal Year 2024 Financial Results and Operations Update
BEIJING, Nov. 13, 2023 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a global technology company that develops and provides products utilizing intelligent acoustics including ultrasound, infrasound and directional sound, and provides 5G messaging, today announced its f...
2023-11-13 21:30
1936
DFS GROUP Collaborates with Galaxy Macau to Spread Positive Energy with Wellness
Discover " The Best Of You, Now "Hong Kong HONG KONG, Nov. 13, 2023 /PRNewswire/ -- This autumn and winter, DFS Group, the world's leading luxury travel retail company, is partnering with Galaxy Macau™ Integrated Resort to launch a wellness-themed event at DFS's first "green" store in their net...
2023-11-13 21:15
1544
PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE
* PYC has developed a new drug candidate for the >5 million people worldwide [1] with Polycystic Kidney Disease (PKD) * This drug candidate has demonstrated efficacy in human models derived from the kidneys of patients with end-stage renal failure due to PKD[2] * PKD is a life-changing diseas...
2023-11-13 21:00
1166
AnchorDx, DiaCarta Partner Developing Novel Cancer Screening Tests
GUANGZHOU, China, Nov. 13, 2023 /PRNewswire/ -- AnchorDx, a leading diagnostics company developing cancer early detection tests, announced today that it has entered into a long-term collaboration with DiaCarta, a precision molecular diagnostics company and developer of novel oncology and infectio...
2023-11-13 21:00
1288
AnchorDx, DiaCarta Partner Developing Novel Cancer Screening Tests
GUANGZHOU, China, Nov. 13, 2023 /PRNewswire/ -- AnchorDx, a leading diagnostics company developing cancer early detection tests, announced today that it has entered into a long-term collaboration with DiaCarta, a precision molecular diagnostics company and developer of novel oncology and infectio...
2023-11-13 21:00
1039
Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)
Bylvay (odevixibat) is the first and only oral treatment available in Canada
for the treatment of pruritus due to this rare genetic condition
ZUG, Switzerland and PARIS, Nov. 13, 2023 /PRNewswire/ -- Today, Ipsen
2023-11-13 20:20
1114
So-Young's Subsidiary Wuhan Miracle Submits Application Documents for Initial Public Offering on China's Beijing Stock Exchange
BEIJING, Nov. 13, 2023 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that its subsidiary Miracle L...
2023-11-13 19:30
1825
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 273 media titles]
2024-04-24 17:09
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
6529
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
2024-04-22 16:00
4461
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
2024-04-22 06:00
4055
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
2024-04-24 17:09
3501
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
2024-04-23 15:43
3410